Exelixis Clinical Site #11

Boston, Massachusetts 02114

1 studies enrolling now · 1 studies all time

What they study most

Advanced Solid Tumor, Immune Sensitive Tumor, Metastatic Solid Tumor, Solid Tumor

Studies at this site

• A Study of XB628 Alone and in Combination With Zanzalintinib in Participants With Recurrent Advanced or Metastatic Solid Tumors — Recruiting now